Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award Chief Operating Officer acquired 12,000 shares (grant or award)
  8. 4 Grant or award CFO and CBO acquired 12,000 shares (grant or award)
  9. 4 Grant or award President and Chief Executive acquired 12,000 shares (grant or award)
  10. 4 Open-market buy Chief Operating Officer bought 20,000 shares at $8.16 ($163,288)
  11. 4 Open-market buy President and Chief Executive bought 20,500 shares at $7.41 ($151,835)
  12. 4 Open-market buy CFO and CBO bought 6,000 shares
  13. 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award CFO and CBO acquired 20,000 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale 10% owner sold 18 shares at $19.00 ($342)
  19. 4/A Insider Changes in Ownership
  20. 4 Open-market buy Director bought 9,798 shares at $19.00 ($186,162)

Page 7 of 12 · 224 filings